QBIO Financial Statements & Analysis
Complete financial statements for QBIO including income statement, balance sheet, and cash flow statement. Analyze QBIO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
45.4% ↑
Net Income
75.1% ↑
Gross Margin
87.9% ↑
Operating Margin
67.9% ↑
Balance Sheet
Current Ratio
-89.4% ↓
Debt to Equity
-36.6% ↑
Asset Turnover
-66.5% ↓
Cash Flow
Operating Cash Flow
145.1% ↑
Net Cash Flow
-276.2% ↓
Free Cash Flow
145.1% ↑
Cash Flow to Debt
133.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2021 | 2022 | Change | Impact |
|---|---|---|---|---|
| Revenue | 195.60K | 284.35K | 45.4% | |
| Gross Profit | -51.25K | -8.99K | 82.5% | |
| Operating Income | -7.39M | -3.45M | 53.4% | |
| Net Income | -8.24M | -2.05M | 75.1% | |
| EPS | -0.33 | -0.08 | 76.3% | |
| EBITDA | -7.68M | -617.63K | 92.0% | |
| Gross Margin | -26.20% | -3.16% | 87.9% | |
| Operating Margin | -3777.44% | -1211.74% | 67.9% | |
| Net Income Margin | -4213.02% | -721.67% | 82.9% | |
| R&D Expenses | 1.07M | 125.38K | 88.3% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 284.35K | 195.60K | 30.00K | — | — |
| Gross Profit | -8.99K | -51.25K | -296.01K | — | — |
| Operating Income | -3.45M | -7.39M | -13.15M | — | — |
| Net Income | -2.05M | -8.24M | -13.49M | — | — |
| EPS | -0.08 | -0.33 | -0.65 | — | — |
| EBITDA | -617.63K | -7.68M | -13.15M | — | — |
| Gross Margin | -3.16% | -26.20% | -986.70% | — | — |
| Operating Margin | -1211.74% | -3777.44% | -43818.05% | — | — |
| Net Income Margin | -721.67% | -4213.02% | -44973.97% | — | — |
| R&D Expenses | 125.38K | 1.07M | 1.88M | — | — |
Financial Metrics
Want to dive deeper into QBIO's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics